255 related articles for article (PubMed ID: 33842373)
21. Synthesis of thiazolidine-2,4-dione derivatives: anticancer, antimicrobial and DNA cleavage studies.
Laxmi SV; Anil P; Rajitha G; Rao AJ; Crooks PA; Rajitha B
J Chem Biol; 2016 Oct; 9(4):97-106. PubMed ID: 27698947
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and in vitro anti-proliferative activity of 4,6-quinazolinediamines as potent EGFR-TK inhibitors.
Mowafy S; Farag NA; Abouzid KA
Eur J Med Chem; 2013 Mar; 61():132-45. PubMed ID: 23142066
[TBL] [Abstract][Full Text] [Related]
23. 1-Benzyl-2-methyl-3-indolylmethylene barbituric acid derivatives: Anti-cancer agents that target nucleophosmin 1 (NPM1).
Penthala NR; Ketkar A; Sekhar KR; Freeman ML; Eoff RL; Balusu R; Crooks PA
Bioorg Med Chem; 2015 Nov; 23(22):7226-33. PubMed ID: 26602084
[TBL] [Abstract][Full Text] [Related]
24. SRS06, a new semisynthetic andrographolide derivative with improved anticancer potency and selectivity, inhibits nuclear factor-κB nuclear binding in the A549 non-small cell lung cancer cell line.
Lim JC; Jeyaraj EJ; Sagineedu SR; Wong WS; Stanslas J
Pharmacology; 2015; 95(1-2):70-7. PubMed ID: 25613753
[TBL] [Abstract][Full Text] [Related]
25. Assessment of iridoids and their similar structures as antineoplastic drugs by
Neupane P; Adhikari Subin J; Adhikari R
J Biomol Struct Dyn; 2024 Feb; ():1-16. PubMed ID: 38345021
[TBL] [Abstract][Full Text] [Related]
26. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
28. Novel 5,6-disubstituted pyrrolo[2,3-d]pyrimidine derivatives as broad spectrum antiproliferative agents: Synthesis, cell based assays, kinase profile and molecular docking study.
Lee JH; El-Damasy AK; Seo SH; Gadhe CG; Pae AN; Jeong N; Hong SS; Keum G
Bioorg Med Chem; 2018 Nov; 26(21):5596-5611. PubMed ID: 30385226
[TBL] [Abstract][Full Text] [Related]
29. An oncoinformatics study to predict the inhibitory potential of recent FDA-approved anti-cancer drugs against human Polo-like kinase 1 enzyme: a step towards dual-target cancer medication.
Rizvi SMD; Alshammari AAA; Almawkaa WA; Ahmed ABF; Katamesh A; Alafnan A; Almutairi TJ; Alshammari RF
3 Biotech; 2019 Mar; 9(3):70. PubMed ID: 30800581
[TBL] [Abstract][Full Text] [Related]
30. Near-Infrared MAO A Inhibitor (NMI) Outperformed FDA-Approved Chemotherapeutic Agents in Brain and Other Cancers: A Bioinformatic Analysis of NCI60 Screening Data.
Feng Q; Lian Y; Qian Y; Shih JC
Brain Sci; 2021 Oct; 11(10):. PubMed ID: 34679383
[TBL] [Abstract][Full Text] [Related]
31. Combined inhibition of the EGFR and mTOR pathways in EGFR wild-type non-small cell lung cancer cell lines with different genetic backgrounds.
Huang Y; Chen Y; Mei Q; Chen Y; Yu S; Xia S
Oncol Rep; 2013 Jun; 29(6):2486-92. PubMed ID: 23525575
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, biological evaluation and virtual screening of some acridone derivatives as potential anticancer agents.
Oyedele AS; Bogan DN; Okoro CO
Bioorg Med Chem; 2020 May; 28(9):115426. PubMed ID: 32201193
[TBL] [Abstract][Full Text] [Related]
33. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone.
Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR
Comput Biol Chem; 2018 Aug; 75():178-195. PubMed ID: 29883916
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor receptors are components of autocrine signaling networks in head and neck squamous cell carcinoma cells.
Marshall ME; Hinz TK; Kono SA; Singleton KR; Bichon B; Ware KE; Marek L; Frederick BA; Raben D; Heasley LE
Clin Cancer Res; 2011 Aug; 17(15):5016-25. PubMed ID: 21673064
[TBL] [Abstract][Full Text] [Related]
35. Identification of
Yeh YC; Lawal B; Hsiao M; Huang TH; Huang CF
Biomedicines; 2021 Oct; 9(11):. PubMed ID: 34829812
[TBL] [Abstract][Full Text] [Related]
36. Network Pharmacological Analysis through a Bioinformatics Approach of Novel NSC765600 and NSC765691 Compounds as Potential Inhibitors of
Mokgautsi N; Wang YC; Lawal B; Khedkar H; Sumitra MR; Wu ATH; Huang HS
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34063946
[TBL] [Abstract][Full Text] [Related]
37. Epidermal growth factor receptor and hedgehog signaling pathways are active in esophageal cancer cells from rat reflux model.
Sui G; Bonde P; Dhara S; Broor A; Wang J; Marti G; Feldmann G; Duncan M; Montgomery E; Maitra A; Harmon JW
J Surg Res; 2006 Jul; 134(1):1-9. PubMed ID: 16488438
[TBL] [Abstract][Full Text] [Related]
38. 3'-(4-(Benzyloxy)phenyl)-1'-phenyl-5-(heteroaryl/aryl)-3,4-dihydro-1'H,2H-[3,4'-bipyrazole]-2-carboxamides as EGFR kinase inhibitors: Synthesis, anticancer evaluation, and molecular docking studies.
Nawaz F; Alam O; Perwez A; Rizvi MA; Naim MJ; Siddiqui N; Pottoo FH; Jha M
Arch Pharm (Weinheim); 2020 Apr; 353(4):e1900262. PubMed ID: 32003485
[TBL] [Abstract][Full Text] [Related]
39. A low-molecular-weight compound exerts anticancer activity against breast and lung cancers by disrupting EGFR/Eps8 complex formation.
Li M; Yang J; Zhang L; Tu S; Zhou X; Tan Z; Zhou W; He Y; Li Y
J Exp Clin Cancer Res; 2019 May; 38(1):211. PubMed ID: 31118055
[TBL] [Abstract][Full Text] [Related]
40. Methyl protogracillin (NSC-698792): the spectrum of cytotoxicity against 60 human cancer cell lines in the National Cancer Institute's anticancer drug screen panel.
Hu K; Yao X
Anticancer Drugs; 2001 Jul; 12(6):541-7. PubMed ID: 11460001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
